We are live on
!
Find out more
William Blair Investment Management Portfolio holdings
AUM
$30.3B
1-Year Est. Return
33.75%
This Fund
S&P 500
This Quarter
Est. Return
-2.5%
1 Year Est. Return
+33.75%
3 Year Est. Return
+108.55%
5 Year Est. Return
+126.9%
10 Year Est. Return
+788.31%
AUM
$49B
AUM Growth
–
Cap. Flow
+$50.2B
Cap. Flow
% of AUM
102.5%
Top 10 Holdings %
Top 10 Hldgs %
6.74%
Holding
1,067
New
1,067
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$358M |
| 2 |
Affiliated Managers Group
AMG
|
+$335M |
| 3 |
Dollar General
DG
|
+$321M |
| 4 |
TSMC
TSM
|
+$320M |
| 5 |
iShares Russell 1000 Value ETF
IWD
|
+$317M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 5.69% |
| 2 | Consumer Discretionary | 5.41% |
| 3 | Financials | 5.33% |
| 4 | Healthcare | 5.32% |
| 5 | Technology | 4.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WLL
401
DELISTED
Whiting Petroleum Corporation
WLL
| $432K | ﹤0.01% |
+94
| New | +$581K |
|
402
AMN Healthcare
AMN
$1.28B
| $426K | ﹤0.01% |
+14,188
| New | +$468K |
|
403
Manhattan Associates
MANH
$11.4B
| $412K | ﹤0.01% |
+6,610
| New | +$412K |
|
404
West Pharmaceutical
WST
$24.7B
| $398K | ﹤0.01% |
+7,345
| New | +$428K |
|
405
Microsoft
MSFT
$3.74T
| $395K | ﹤0.01% |
+8,932
| New | +$401K |
|
406
Gentex
GNTX
$5.04B
| $376K | ﹤0.01% |
+24,266
| New | +$386K |
|
407
Omega Flex
OFLX
$302M
| $369K | ﹤0.01% |
+11,042
| New | +$375K |
|
408
Trimble
TRMB
$13.5B
| $359K | ﹤0.01% |
+21,871
| New | +$441K |
|
|
DWRE
409
DELISTED
DEMANDWARE INC COM STK (DE)
DWRE
| $350K | ﹤0.01% |
+6,780
| New | +$419K |
|
410
Oil States International
OIS
$532M
| $344K | ﹤0.01% |
+13,149
| New | +$389K |
|
411
Varonis Systems
VRNS
$4.84B
| $338K | ﹤0.01% |
+65,091
| New | +$453K |
|
412
Vanguard FTSE Emerging Markets ETF
VWO
$125B
| $331K | ﹤0.01% |
+10,000
| New | +$363K |
|
|
ESRX
413
DELISTED
Express Scripts Holding Company
ESRX
| $316K | ﹤0.01% |
+3,898
| New | +$340K |
|
414
Ameriprise Financial
AMP
$49.7B
| $289K | ﹤0.01% |
+2,652
| New | +$313K |
|
415
Colgate-Palmolive
CL
$73.6B
| $251K | ﹤0.01% |
+3,950
| New | +$258K |
|
416
Chevron
CVX
$386B
| $251K | ﹤0.01% |
+3,178
| New | +$268K |
|
417
Regions Financial
RF
$26.9B
| $103K | ﹤0.01% |
+11,423
| New | +$113K |
|
Similar funds
William Blair Investment Management's Q3 2015 Portfolio in Review
Q3 2015 is the first quarter with a 13F filing on record for William Blair Investment Management, which disclosed 1,067 positions worth $49B. Its ten largest holdings account for 6.7% of the portfolio.
Its largest position is Teva Pharmaceuticals: 5,521,241 shares worth $312M.
By sector, the portfolio is most concentrated in Industrials at 5.7% of assets, followed by Consumer Discretionary and Financials.
- William Blair Investment Management's largest Q3 2015 buy was Teva Pharmaceuticals: 5,521,241 shares worth $312M.
- William Blair Investment Management's ten largest holdings make up 6.7% of its $49B portfolio in Q3 2015.
- William Blair Investment Management disclosed 1,067 positions in Q3 2015, its first 13F filing on record.
Based on William Blair Investment Management's 13F filing for Q3 2015, filed 12 Nov 2015.